SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

M12 (M12) News

Follow M12 (M12) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol M12 Asset market Sector Markets 90 days 7 Updated Sep 24, 2026, 09:24 AM UTC Open live news feed
L StarHub May Have to Raise Equity to Finance Potential M1 Deal — Market Talk StarHub may have to raise equity to finance a potential deal to buy peer M1, says Macquarie Capital's Zhiwei Foo in a note. StarHub confirmed it is in talks with M1 owner Keppel Ltd. to acquire the telecommunications uni MNA | Sep 24, 2026, 09:24 AM UTC L StarHub in Talks to Acquire Keppel's M1 (22:53 GMT) *StarHub: In Talks With Keppel Ltd. Regarding Possible Deal for M1 (22:55 GMT) *StarHub: Discussions Continuing; No Certainty or Assurance of Deal (00:28 GMT) StarHub in Talks to Acquire Keppel's M1By Amanda MNA | Sep 24, 2026, 12:36 AM UTC L Starhub In Discussions With Keppel Regarding Possible Transaction For M1 Limited StarHub Ltd SGX:CC3 NEWS | Sep 23, 2026, 03:30 PM UTC L M1 Kliniken: Beauty growth lifts margins as trading exit completes M1 Kliniken says its Beauty segment delivered double-digit revenue and EBIT growth, while the trading segment was exited after selling HAEMATO Pharm GmbH. Group EBIT margin improved significantly; targets EUR 200–300 mil EARNINGS | Sep 09, 2026, 06:45 AM UTC L Aesthetic clinic operator M1 Kliniken H1 revenue falls as HAEMATO Pharm disposal cuts trading sales OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed EARNINGS | Sep 09, 2026, 06:43 AM UTC L M1 Kliniken margins and profitability surge after strategic realignment M1 Kliniken’s refocus on aesthetic medicine cut group sales but lifted margins and profitability. The Beauty segment grew double digits with improved EBIT, while equity and liquidity strengthened. A EUR 1.20 dividend per EARNINGS | Sep 09, 2026, 06:35 AM UTC L StarHub seen as only viable local buyer for M1: Citi note Citi analyst Arthur Pineda says StarHub is likely the only viable local buyer for M1 if Keppel is willing to sell after SIMBA’s cancelled bid. M1 pricing would likely need revision lower from SIMBA’s S$1.43 billion offer EQUITY | Sep 09, 2026, 05:32 AM UTC